Physician profile
Brian Olshansky
NPI 1962483347
$218,829.29
in general payments reported to CMS, 2019-2025
34 companies · $4,988 in 2025
The $4,988 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142K · 2020: $39K · 2021: $9,283 · 2022: $13K · 2023: $7,825 · 2024: $2,273 · 2025: $4,988.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,151 · Consulting Fee: $5,063 · Honoraria: $1,750 · Travel and Lodging: $1,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,150.75 |
| Consulting Fee | $5,063.00 |
| Honoraria | $1,750.00 |
| Travel and Lodging | $1,122.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $109,991.75 | 2019-2020 | |
| Amarin Pharma, INC. | $26,729.51 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21,658.44 | 2019-2023 | Jardiance |
| Sanofi-Aventis U.S. LLC | $18,415.98 | 2019-2021 | |
| Abbott Laboratories | $8,909.95 | 2019-2025 | Ensite, Aveir, Tacticath Ablation Catheter, Sensor Enabled |
| Atricure, INC. | $7,840.18 | 2022-2024 | |
| Zoll Respicardia, INC. | $4,161.59 | 2019-2020 | |
| Altathera Pharmaceuticals LLC | $4,015.97 | 2022-2025 | Sotalol Hydrochloride |
| Astrazeneca Pharmaceuticals LP | $3,513.84 | 2019-2023 | Lokelma |
| Boston Scientific Corporation | $3,331.84 | 2019-2025 | Resonate El Icd Vr, General - Therapies, Ingevity+ |
| Biosense Webster, INC. | $3,216.29 | 2019-2025 | Carto 3, Nuvision Ice Catheter, Qdot Micro Catheter |
| Medtronic Vascular, INC. | $1,970.64 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $881.11 | 2023-2025 | Optimizer, Optimizer |
| Irhythm Technologies, INC. | $734.27 | 2019-2022 | |
| Infobionic, INC | $450.34 | 2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Artivion, INC. | $400.00 | 2021 | |
| Janssen Pharmaceuticals, INC | $358.69 | 2019-2024 | Xarelto |
| Medtronic, INC. | $270.39 | 2021-2025 | Micra, Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan |
| Cardiva Medical, INC. | $223.74 | 2023-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| E.R. Squibb & Sons, L.L.C. | $222.84 | 2019-2024 | Camzyos |
| Boehringer Ingelheim International Gmbh | $213.50 | 2019 | |
| Biotronik INC. | $211.09 | 2019-2025 | Amvia Edge, Acticor 7 Vr-T Dx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $197.27 | 2019-2025 | Lifevest |
| Elutia, INC. | $194.18 | 2023-2024 | Ecm Patch,Pouch |
| Philips North America LLC | $168.92 | 2019-2025 | Mechanical Tools |
| Aidoc Medical LTD | $131.00 | 2023 | Briefcase |
| Amgen INC. | $101.97 | 2019 | |
| Novartis Pharmaceuticals Corporation | $91.32 | 2019-2020 | |
| Csl Behring | $79.73 | 2019 | |
| Pfizer INC. | $56.22 | 2019 | |
| Esperion Therapeutics, INC. | $36.24 | 2024 | Nexletol |
| Novo Nordisk INC | $24.07 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $13.98 | 2019 | |
| Cook Medical LLC | $12.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Olshansky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.